Breaking news

SAP Surpasses Novo Nordisk To Become Europe’s Largest Company

SAP, the German software company, has officially overtaken Danish pharmaceutical giant Novo Nordisk to become Europe’s largest company by market capitalization. SAP’s market value reached $340 billion, surpassing Novo Nordisk’s $293.06 billion.

Key Factors Behind SAP’s Rise

SAP has experienced significant stock growth, particularly driven by optimism around its cloud business and its investments in generative artificial intelligence (AI). Since the start of 2025, SAP’s shares have risen 7%, and the company has seen a total return of 160% since the end of 2022, substantially outpacing the broader European STOXX 600 index, which rose by only 28%. The company’s increasing focus on cloud technologies and AI solutions for business applications has positioned it as a leader in digital transformation.

In recent months, strong investor interest has further propelled SAP’s growth, spurred by its expanding cloud services portfolio, AI developments, and strategic partnerships with large international corporations. These factors, alongside improvements to SAP’s ERP systems, have helped the company secure its top position.

Challenges For Novo Nordisk

In contrast, Novo Nordisk, which held the title of Europe’s largest company as recently as September 2023, has seen its stock lag due to disappointing results from its experimental obesity drug, Cagrisema. This has led to a slight decline in its market value, despite its strong performance in the pharmaceutical industry.

What This Means For The Future

The rise of SAP highlights the growing dominance of the technology sector in Europe, with digital transformation and AI solutions becoming key areas of investor focus. While Novo Nordisk is likely to remain a major player in the pharmaceutical industry, SAP’s success suggests that the European technology sector could experience even more growth, particularly with the increasing importance of AI and automation in business.

Looking ahead, competition between tech giants such as SAP and ASML is expected to intensify, marking the beginning of a new era for Europe’s technology-driven economy.

Ultrahuman Unveils Ring Pro As Smart Ring Competition Intensifies In The U.S.

Ultrahuman, the Bengaluru-based leader in wearable technology, has unveiled its third-generation smart ring, the Ring Pro, marking a significant step in the company’s efforts to reestablish its U.S. presence. With an extended battery life of up to 15 days and a completely redesigned form factor, the Ring Pro arrives as a strategic response following last year’s patent dispute with rival Oura.

New Design And Extended Battery Life

Ring Pro introduces a redesigned form factor alongside a dual-core processor and upgraded heart-rate sensing architecture aimed at improving data accuracy. The device is slightly heavier than its predecessor but offers enhanced on-device computing and the ability to store up to 250 days of health data. Priced at $479, the ring delivers up to 15 days of battery life, a notable increase compared to the four to six days offered by the Ring Air.

Overcoming Regulatory And Patent Hurdles

Ultrahuman’s U.S. operations faced disruption in October 2025 after the U.S. International Trade Commission ruled in favor of Oura in a patent dispute, restricting imports of new inventory. Existing stock remained available, but the decision pushed the company to redesign the product and reassess its U.S. strategy. The market remains critical for Ultrahuman, with American users accounting for roughly 45% of its 700,000 daily active users.

Introducing Jade: Real-Time Biointelligence

Alongside Ring Pro, Ultrahuman launched Jade, a real-time biointelligence system designed to provide actionable health insights instead of retrospective data summaries. According to co-founder and CEO Mohit Kumar, the system focuses on continuous analysis and real-time recommendations. Jade is available across the company’s ecosystem, including older ring models, reinforcing Ultrahuman’s AI-driven approach to wearable health monitoring.

Robust Financials And Expanding Market Influence

Despite legal and operational challenges, Ultrahuman continues to show strong financial performance. The company reports an annualized revenue run rate of approximately $150 million and operating revenue of $64 million for the fiscal year ending March 2025. Subscription services and additional offerings, including coaching programs and continuous glucose monitoring, continue to diversify revenue streams and support profitability.

Expanding Production And Global Reach

Ultrahuman is expanding production capacity as demand grows across international markets, including the UK, Canada, Australia, and India. Industry analysts note that the future of smart rings will depend on sensor precision, AI integration, and ecosystem connectivity — areas where Ultrahuman is actively investing.

With the launch of Ring Pro and the introduction of Jade, the company is aiming to strengthen its position in the fast-growing wearable technology sector while rebuilding momentum in key global markets.

The Future Forbes Realty Global Properties
Aretilaw firm
eCredo
Uol

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter